Table 1.
Comparison of reporting rates for tumor location descriptors and other study characteristics for surgical vs. percutaneous cryoablation literature (n= number of cohorts).
| Surgical Cryotherapy Cohorts | Percutaneous Cryotherapy Cohorts | p value | |
|---|---|---|---|
|
| |||
| Reported location descriptor: | |||
|
| |||
| Any Location Descriptor | 18/29 (62%) | 12/15 (80%) | 0.34 |
| Ant/Post/Lat Descriptor | 9/29 (31%) | 7/15 (47%) | 0.34 |
| Endo/meso/exo Descriptor | 5/29 (17%) | 6/15 (40%) | 0.14 |
| Upper/mid/lower pole Descriptor | 14/29 (48%) | 7/15 (47%) | 1 |
|
| |||
| Other Study Characteristics | |||
|
| |||
| Multi-institutional series | 2/29 (7%) | 2/15 (13%) | 1 |
|
| |||
| Retrospective chart review | 29/29 (100%) | 13/15 (87%) | 0.1 |
|
| |||
| Comorbidity reporting rate | 8/29 (28%) | 3/15 (20%) | 0.24 |